Analysis reveals a prognostic model based on anoikis-related genes in colorectal cancer, indicating potential for patient risk stratification.
Colorectal cancer (CRC) is a most deadly cancer, and effective prognostic biomarkers are urgently needed. Although anoikis has diverse regulatory roles in tumor progression, the impact of anoikis-related genes (ANRG) by single-cell and bulk transcriptome analyses on the prognostic value for CRC have not been studied. Differentially expressed genes (DEGs) associated with anoikis were obtained by performing single-cell RNA-sequencing (scRNA-seq) analysis in cells with high and low ANRG expression and weighted correlation network analysis (WGCNA) in a bulk RNA sequencing dataset. Key prognostic genes were selected from anoikis associated DEGs by least absolute shrinkage and selection operator (LASSO)-Cox regression analysis, and a prognostic model was established based on the risk score calculated from the expression levels of the identified key prognostic genes. A 10 anoikis-related-gene prognostic model (MGP, TPM2, CRIP2, TUBB6, C1orf54, NOTCH3, LTBP1, CSRP2, FSTL3, and VIM) was developed and the area under the curve (AUC) values of the model in predicting 1-, 3- and 5-year survival probabilities reached 0.744, 0.797, and 0.755, respectively. In conclusion, anoikis related genes could be promising prognostic factors for risk stratification of CRC patients.
No takes yet. Share an insight, caveat, or question.
Yang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: